Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings

INTRODUCTION: The aim of this study was to understand the reasons for canakinumab initiation among patients with Still’s disease, including systemic juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD), in US clinical practice. METHODS: Physicians retrospectively reviewed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hur, Peter, Yi, Esther, Ionescu-Ittu, Raluca, Manceur, Ameur M., Lomax, Kathleen G., Cammarota, Jordan, Xie, Jipan, Gautam, Raju, Nakasato, Priscila, Sanghera, Navneet, Kim, Nina, Grom, Alexei A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814295/
https://www.ncbi.nlm.nih.gov/pubmed/34874547
http://dx.doi.org/10.1007/s40744-021-00402-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814295/
https://www.ncbi.nlm.nih.gov/pubmed/34874547
http://dx.doi.org/10.1007/s40744-021-00402-z

Ejemplares similares